Chris Lowe

Track

Insider profile

Currently holds positions in Diadexus Inc and Quince Therapeutics, Inc.

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -37% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Accounting Officer Diadexus Inc March 2, 2015 -
Chief Financial Officer, Treasurer Quince Therapeutics, Inc. April 1, 2019 -
Chief Financial Officer Quince Therapeutics, Inc. Jan. 1, 2019 - April 1, 2019
Interim Chief Financial Officer Quince Therapeutics, Inc. June 1, 2018 - Jan. 1, 2019
Interim Chief Financial Officer, Chief Accounting Officer Diadexus Inc Dec. 22, 2014 - March 2, 2015
Chief Financial Officer, Chief Business Officer Anthera Pharmaceuticals Inc Feb. 1, 2011 - June 30, 2013
Chris Lowe's trades of Vincerx Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
156.39
Quantity 81,254 -39.8%
Value US$3,764,121
Transaction date
Purchase
Price
43.95
Quantity 19,393 -49.8%
Value US$3,450,083
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-26 2022-08-25
B Purchase
81,254 -39.8%
156.39
US$3,764,121 		81,254 -39.8% 156.39 US$3,764,121
2022-08-26 2022-08-24
B Purchase
19,393 -49.8%
43.95
US$3,450,083 		19,393 -49.8% 43.95 US$3,450,083
2021-10-07 2021-10-05
PlS Planned sale
52,917 -36.9%
246.39
US$2,493,634 		52,917 -36.9% 246.39 US$2,493,634